One major challenge in measuring prevalence is the diversity of exposure sources and pathways. Additionally, variations in individual susceptibility and the presence of multiple toxins complicate assessments. Accurate data collection can be hindered by limited access to advanced technology and insufficient funding for large-scale studies.
